DANTARI
Developer of a pharmaceutical platform and drugs created for the treatment of the central nervous system. The company's platform and therapies specialize in the research and development of small and large molecule therapeutics across the blood-brain barrier, enabling clients to have rapidly advance therapies to treat the patients and provide meaningful medical improvement in their lives.
DANTARI
Industry:
Life Science
Founded:
2018-01-01
Address:
Thousand Oaks, California, United States
Country:
United States
Website Url:
http://www.dantari.com
Total Employee:
11+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Investors List
Westlake Village BioPartners
Westlake Village BioPartners investment in Funding Round - Dantari
Corner Ventures
Corner Ventures investment in Funding Round - Dantari
Official Site Inspections
http://www.dantari.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Dantari"
Dantari - Crunchbase Company Profile & Funding
Developer of a pharmaceutical platform and drugs created for the treatment of the central nervous system.See details»
Dantari 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Dantari. Use the PitchBook Platform to explore the full profile.See details»
Dantari, Inc. Information - RocketReach
Dantari, Inc. is a Biotechnology Research, Biotechnology, and Drug Discovery company located in Thousand Oaks, California with 7 employees. Find top employees, contact details and …See details»
Dantari emerges with a new way to make cancer drug …
Dec 8, 2022 As the success of drugs like Enhertu catalyzes new investment in antibody-drug conjugates, the California startup is launching with plans to develop more potent versions of the targeted cancer medicines.See details»
Dantari - Products, Competitors, Financials, Employees, …
Dantari is a clinical stage biotechnology company that focuses on creating breakthrough therapies for the treatment of cancer and other serious diseases. Use the CB Insights Platform to …See details»
Dantari, Inc. Company Profile | Westlake Village, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Dantari, Inc. of Westlake Village, CA. Get the latest business insights from Dun & Bradstreet.See details»
Dantari Company Profile - Office Locations, Competitors ... - Craft
Dantari has 5 employees at their 1 location and $47 m in total funding,. See insights on Dantari including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Dantari Pharmaceuticals - VentureRadar
"Dantari is a Los Angeles area biotechnology company committed to creating breakthrough medicines for the treatment of cancer and other serious diseases. Using our proprietary …See details»
Dantari - Overview, News & Similar companies | ZoomInfo.com
Dec 7, 2022 View Dantari (www.dantari.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
About Dantari - Biotech company in United States | F6S
About Dantari Dantari is a clinical stage biotechnology company committed to creating breakthrough therapies for the treatment of cancer and other serious diseases. We are excited …See details»
Dantari Company Profile | Management and Employees List
Find contact information for Dantari. Learn about their Research & Development, Business Services market share, competitors, and Dantari's email format.See details»
Westlake-Backed Dantari Launches With $47 million Series A
Dec 8, 2022 Dantari, Inc., a clinical-stage biotechnology company developing best-in-class targeted therapeutics for the treatment of cancers and other diseases, announced its …See details»
Annual Report on Dantari's Revenue, Growth, SWOT Analysis
Dantari's annual revenues are $1-$10 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Marketing Research & Public Opinion Polling …See details»
Dantari Gets $47M For Tumor Medicine Effort - socaltech.com
Dec 8, 2022 Thousand Oaks-based Dantari has raised $47M in its Series A funding, saying that it has launched a new, clinical-stage biotechnology company developing targeted therapeutics …See details»
Dantari - Contacts, Employees, Board Members, Advisors & Alumni
Dantari has 1 current employee profile, Founder,President and CEO Richard Markus. Dantari has 4 board members and advisors, including Warren .See details»
Dantari raises $47M to target cancers and rare diseases
Dec 16, 2022 Dantari headquarters and lab is based in Thousand Oaks. A few years ago, Richard Markus was heading up Amgen’s biosimilar division, a role he enjoyed — finding a …See details»
Dantari Debuts with $47 Million Series A to Advance Best-in-Class ...
Dec 8, 2022 /PRNewswire/ -- Dantari, Inc. ("Dantari"), a clinical-stage biotechnology company developing best-in-class targeted therapeutics for the treatment of cancers...See details»
Dantari - Updates, News, Events, Signals & Triggers - Crunchbase
Developer of a pharmaceutical platform and drugs created for the treatment of the central nervous system.See details»
dantari.com
Dantari.comSee details»
Dantari targets solid tumors with $47 million Series A financing
Dec 8, 2022 Biotech start-up Dantari has announced its exit from stealth mode with a $47 million Series A financing. The round was led by Westlake Village BioPartners and included …See details»